Cargando…

The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling

Evaluations of healthcare interventions, e.g. new drugs or other new treatment strategies, commonly include a cost-effectiveness analysis (CEA) that is based on the application of health economic (HE) models. As end users, patients are important stakeholders regarding the outcomes of CEAs, yet their...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Voorn, George A. K., Vemer, Pepijn, Hamerlijnck, Dominique, Ramos, Isaac Corro, Teunissen, Geertruida J., Al, Maiwenn, Feenstra, Talitha L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791454/ https://www.ncbi.nlm.nih.gov/pubmed/26385585 http://dx.doi.org/10.1007/s40258-015-0200-7

Ejemplares similares

Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research
por: van Asselt, Thea, et al.
Publicado: (2017)

AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users
por: Vemer, P., et al.
Publicado: (2015)

Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer
por: de Boer, Pieter T., et al.
Publicado: (2016)

The Diversity of Biosimilar Design and Development: Implications for Policies and Stakeholders
por: Grampp, Gustavo, et al.
Publicado: (2015)

Why Does the Precautionary Principle Suffice for Blood Regulation?
por: Seifner, Alexandra, et al.
Publicado: (2021)

Why the Gap in Evaluating the Social Constructs and the Value of Medicines?
por: McRae, Jacquelyn, et al.
Publicado: (2021)

How a Bottom-Up Multi-Stakeholder Initiative Helped Transform the Renal Replacement Therapy Landscape in Spain
por: Selgas, Rafael, et al.
Publicado: (2017)

Antimicrobial Agents are Societal Drugs: How Should This Influence Prescribing?
por: Sarkar, Paul, et al.
Publicado: (2012)

Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?
por: Edan, Gilles, et al.
Publicado: (2013)

What Should We Do About Habitual Caffeine Use in Athletes?
por: Pickering, Craig, et al.
Publicado: (2018)

Assessments of the Value of New Interventions Should Include Health Equity Impact
por: Jansen, Jeroen P., et al.
Publicado: (2022)

Using Economics to Impact Local Obesity Policy: Introducing the UK Centre for Economics of Obesity (CEO)
por: Frew, Emma, et al.
Publicado: (2022)

Insulins as Drugs or Biologics in the USA: What Difference Does it Make and Why Does it Matter?
por: George, Kelly, et al.
Publicado: (2019)

Malaria and Economic Evaluation Methods: Challenges and Opportunities
por: Drake, Tom L., et al.
Publicado: (2017)

Research into the Health Benefits of Sprint Interval Training Should Focus on Protocols with Fewer and Shorter Sprints
por: Vollaard, Niels B. J., et al.
Publicado: (2017)

Do Non-Responders to Exercise Exist—and If So, What Should We Do About Them?
por: Pickering, Craig, et al.
Publicado: (2018)

Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients?
por: Rubinstein, Israel, et al.
Publicado: (2019)

Mix and match. A simulation study on the impact of mixed-treatment comparison methods on health-economic outcomes
por: Vemer, Pepijn, et al.
Publicado: (2017)

Attributes of Expert Anticipation Should Inform the Design of Virtual Reality Simulators to Accelerate Learning and Transfer of Skill
por: Müller, Sean, et al.
Publicado: (2022)

Health-Economic Analyses of Diagnostics: Guidance on Design and Reporting
por: van der Pol, Simon, et al.
Publicado: (2021)

Use of Value of Information in Healthcare Decision Making: Exploring Multiple Perspectives
por: Bindels, Jill, et al.
Publicado: (2015)

Why (and how) we should publish negative data
por: Nimpf, Simon, et al.
Publicado: (2019)

Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?
por: Plocque, Alexia, et al.
Publicado: (2022)

Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
por: Concordet, Didier, et al.
Publicado: (2019)

Revision of Ireland’s Cost-Effectiveness Threshold: New State-Industry Drug Pricing Deal Should Adequately Reflect Opportunity Costs
por: O’Mahony, James F.
Publicado: (2021)

Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?
por: Jit, Mark, et al.
Publicado: (2016)

Using Health Economics to Inform Immunization Policy Across All Levels of Government
por: Rafferty, Ellen, et al.
Publicado: (2022)

Why should everybody care about special care dentistry?
por: Britton, Jada, et al.
Publicado: (2021)

Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics
por: Boden, William E, et al.
Publicado: (2020)

Should Heartbeats/Training Session Be Considered When Comparing the Cardiovascular Benefits of High-Intensity Interval Aerobic and Moderate-Intensity Continuous Training? A Critical Appraisal
por: Rodrigues, Jhennyfer Aline Lima, et al.
Publicado: (2020)

Health Inequalities: To What Extent are Decision-Makers and Economic Evaluations on the Same Page? An English Case Study
por: Hinde, Sebastian, et al.
Publicado: (2022)

Exercise Professionals with Advanced Clinical Training Should be Afforded Greater Responsibility in Pre-Participation Exercise Screening: A New Collaborative Model between Exercise Professionals and Physicians
por: Maiorana, Andrew J., et al.
Publicado: (2018)

Principles of Economic Evaluation in a Pandemic Setting: An Expert Panel Discussion on Value Assessment During the Coronavirus Disease 2019 Pandemic
por: Asukai, Yumi, et al.
Publicado: (2021)

Economic Evaluation Evidence for Resource-Allocation Decision Making: Bridging the Gap for Local Decision Makers Using English Case Studies
por: Howdon, Daniel, et al.
Publicado: (2022)

Why ERS Early Career Members should attend the International Congress 2019 in Madrid
por: Ubags, Niki, et al.
Publicado: (2019)

Why we need to integrate mental health into pandemic planning
por: Brewin, CR, et al.
Publicado: (2020)

Why RGB Imaging Should be Used to Analyze Fusarium Graminearum Growth and Estimate Deoxynivalenol Contamination
por: Cambaza, Edgar, et al.
Publicado: (2019)

The Reason Beer Makes You Pee and Why You Should Abstain before Orthopedic Surgery
por: Briguglio, Matteo
Publicado: (2023)

Attention Deficit Hyperactivity Disorder Misdiagnosis: Why Medical Evaluation Should Be a Part of ADHD Assessment
por: Sadek, Joseph
Publicado: (2023)

Clinical studies in the elderly – Why and how should we care?
por: Sousa, Nuno
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tgndpd9rjbkkua4m7l6aemnae5